Moawia Mohammed Ali Elhassan, Associate Professor at University of Gezira, shared a post on LinkedIn shared a recent article by Rusha Bhandari et al, published in Journal of Clinical Oncology:
“Health Outcomes Beyond Age 50 Years in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.
Published in the Journal of Clinical Oncology, a new study on 7,490 childhood cancer survivors over age 50 provides crucial insights and underscores the need for continued, long-term care for this growing population.
Study Highlights:
- While the overall standardized mortality ratio (SMR) was 3.2, it was highest for deaths due to new cancer, at an SMR of 4.7.
- Survivors have a >3-fold increased risk of multiple severe Chronic Health Conditions compared to their siblings.
- Secondary Cancers: 7.6% of survivors developed a new cancer after age 50. Radiation therapy was identified as a primary driver, accounting for 40% of these cases.
- Survivors had higher rates of bone and soft tissue, thyroid, hematologic, breast, GI, and pulmonary cancers compared with the general population.
No link was found between chemotherapy and late-stage health outcomes.
Since most survivors in this study were treated between 1970 and 1980, its findings are most applicable to patients with similar diagnoses and treatments from that time.
These results emphasize the importance of lifelong screening & specialized care to address the unique health challenges survivors face as they age.”
Title: Health Outcomes Beyond Age 50 Years in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.
Authors: Rusha Bhandari, Yan Chen, Eric J. Chow, Rebecca M. Howell, Lisa B. Kenney, Kevin R. Krull, Wendy Leisenring, Paul C. Nathan, Joseph P. Neglia, Kirsten K. Ness, Kevin C. Oeffinger, Claire Snyder, Lucie M. Turcotte, F. Lennie Wong, Yutaka Yasui, Gregory T. Armstrong, Saro H. Armenian.
Read the full article on Journal of Clinical Oncology.
Read more posts featuring Moawia Mohammed Ali Elhassan, on OncoDaily.